ZORIFERTINIB

Clinical trials for ZORIFERTINIB explained in plain language.

Never miss a new study

Get alerted when new ZORIFERTINIB trials appear

Sign up with your email to follow new studies for ZORIFERTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy targets brain lining spread in lung cancer patients

Disease control Not yet recruiting

This study tests a combination of the drug zorifertinib and chemotherapy given directly into the fluid around the brain for people with a type of lung cancer (NSCLC) that has spread to the lining of the brain. The goal is to control the disease and shrink or stop the growth of th…

Matched conditions: ZORIFERTINIB

Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated May 04, 2026 16:21 UTC

ZORIFERTINIB

Get alerted when new ZORIFERTINIB trials appear

New combo therapy targets brain lining spread in lung cancer patients